首页> 外国专利> PROCEDURES AND TESTS TO DISTINGUISH BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND / OR BY SPONTANEOUS INTERACTION BETWEEN THE VON WILLEBRAND FACTOR (VWF) AND THE PLATES.

PROCEDURES AND TESTS TO DISTINGUISH BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND / OR BY SPONTANEOUS INTERACTION BETWEEN THE VON WILLEBRAND FACTOR (VWF) AND THE PLATES.

机译:区分血栓性细胞减少症和/或冯·威勒伯兰德因子(VWF)与板之间自发相互作用所表征的疾病和疾病的不同形式的程序和试验。

摘要

- A procedure to distinguish between different states or forms of diseases and disorders characterized by thrombocytopenia and / or the spontaneous interaction between von Willebrand factor (vWF) and platelets, and / or to predict the progression of said disease or disorder, said procedure comprising the steps of: a) providing at least one biological sample containing vWF obtained from a patient suffering from, or suspected of suffering from, at least one disease or disorder characterized by thrombocytopenia and / or by the spontaneous interaction between vWF and platelets; b) determining the amount of vWF that is in a Gplb binding conformation in said biological sample; and c) comparing the amount obtained from vWF that is in a Gplb binding conformation with a reference value obtained from a patient or a group of patients with or without a different state or form of said disease or disorders; and d) in which the amount of vWF that is in a Gplb binding conformation is determined by contacting the biological sample with a binding agent that is capable of selectively binding to the vWF that is in a Gplb binding conformation in the presence of vWF that is in a non-Gplb binding conformation, and then determining the amount of vWF that is in a Gplb binding conformation bound to the binding agent. wherein the binding agent has a differentiated binding site of the Gplbα binding site, and wherein the binding agent is an antibody; a part or fragment of an antibody; or a protein or a polypeptide that contains one or more parts or fragments of an antibody.
机译:-区分以血小板减少和/或von Willebrand因子(vWF)与血小板之间的自发相互作用为特征的疾病和病症的不同状态或形式的程序,和/或预测所述疾病或病症的进展的程序,所述程序包括步骤:a)提供至少一种含有vWF的生物学样品,该样品得自患有或怀疑患有至少一种以血小板减少和/或vWF与血小板之间的自发相互作用为特征的疾病或病症的患者; b)确定所述生物样品中具有Gplb结合构象的vWF的量; c)比较从具有Gplb结合构象的vWF获得的量与从患有或不患有所述疾病或病症的不同状态或形式的患者或一组患者中获得的参考值; d)其中通过使生物样品与能够选择性结合具有Gplb结合构象的vWF的结合剂接触生物样品来确定具有Gplb结合构象的vWF的量,其中非Gplb结合构象中的vWF含量,然后确定与结合剂结合的Gplb结合构象中的vWF量。其中所述结合剂具有Gplbα结合位点的分化结合位点,并且其中所述结合剂是抗体。抗体的一部分或片段;或包含抗体一个或多个部分或片段的蛋白质或多肽。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号